Condition

Blood Cancer clinical trials and research

• 16Clinical trials
• 3NIH research projects
• 7Countries

Newest Blood Cancer clinical trials

All recruiting trials (16)

• Genetics of Blood Cancers in the U.S. population

  This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07714044

• Multi-biomarker panel to predict prognosis and treatment response in intestinal acute graft-versus-host disease

  This study will test whether a set of clinical and lab biomarkers can predict who will do well or poorly and who will respond to treatment for intestinal acute GvHD after an allogeneic stem cell transplant.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07305090

• Targeting measurable residual AML with tagraxofusp plus azacitidine and venetoclax

  This trial tests whether adding tagraxofusp to azacitidine and venetoclax can safely help control measurable residual acute myeloid leukemia (AML) in adults who are in remission but still have detectable disease.

  Recruiting at 2 sites Phase 1/2 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07148180

• Telehealth music therapy for cognitive difficulties in blood cancer survivors

  This program will test whether telehealth music therapy can help adults who survived leukemia, lymphoma, or myeloma and who are having trouble with memory, attention, or thinking.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07052916

• Personalized T cells engineered to target TP53 or RAS mutations in blood cancers

  This trial will try using a patient's own T cells, modified to recognize specific TP53 or RAS mutations, to treat adults with certain blood cancers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06904066

• Pharmacogenomics to improve voriconazole dosing for fungal infections

  This trial will test whether using a patient's CYP2C19 genotype with Bayesian dosing software helps get voriconazole levels into the therapeutic range by Day 8 for people with fungal infections, including those with blood cancers.

  Recruiting at 7 sites Phase 2 The University of Queensland · Seattle, Washington and 6 other locations · NCT06510699

• Effects of nutrient timing on cancer-related fatigue

  This study is testing if eating all meals within a 10-hour window can help cancer survivors with blood cancers feel less tired and improve their quality of life.

  Recruiting Phase 2 University of Maryland, Baltimore · Baltimore, Maryland · NCT06482515

• Enhancing diversity in clinical trial enrollment through community engagement

  This study is trying to see if getting feedback from patients and community members can help make clinical trials for blood cancer and leukemia more inclusive and diverse.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT06469307

• Daily adapted physical activity to improve sleep in children 5–16 with blood cancer

  This trial will see if doing adapted physical activity every day instead of only once over four days improves sleep for children aged 5–16 who are receiving treatment for blood cancers.

  Recruiting University Hospital, Clermont-Ferrand · Clermont-Ferrand · NCT06455592

• Platform for Rare Blood Disorders in Europe

  This study is trying to gather and share information about rare blood disorders across Europe to help researchers understand these conditions better and improve treatment options for patients.

  Recruiting Hospital Universitari Vall d'Hebron Research Institute · Barcelona, Catalonia · NCT06250595

• IDP-023 treatment for advanced blood cancers

  This study is testing a new treatment called IDP-023, which uses special immune cells alone and with other medications to see if it can help people with advanced blood cancers like multiple myeloma and non-Hodgkin lymphoma.

  Recruiting at 9 sites Phase 1/2 Indapta Therapeutics, INC. · Los Angeles, California and 11 other locations · NCT06119685

• Assessing immune profiles to predict responses to cancer immunotherapy

  This study is testing if certain immune profiles can help predict how well cancer patients will respond to approved immunotherapy treatments.

  Recruiting Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire · NCT06116032

• Improving quality of life for blood cancer patients receiving cellular therapy

  This study is testing a new palliative care program called PEACE to see if it can improve the quality of life for blood cancer patients getting cellular therapy.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT05646576

• KCAT19 T cells for relapsed or refractory B cell cancers

  This study tests KCAT19 T cells, a gene-modified cell therapy, in adults with high-risk B cell cancers that have come back or stopped responding to treatment.

  Recruiting Phase 1 University College, London · London · NCT05391490

• National Research Registry for Blood Cancer Experiences

  This study is collecting personal experiences and medical information from people with blood cancer to help improve treatments and understand their journeys through diagnosis and treatment.

  Recruiting Blood Cancer United · Rye Brook, New York · NCT04806295

• Improving leukemia diagnosis using artificial intelligence

  This study is testing whether an artificial intelligence system can improve the diagnosis of leukemia by comparing its accuracy and speed to traditional methods using a large set of blood samples.

  Recruiting Munich Leukemia Laboratory · Munich, Bavaria · NCT04466059

NIH-funded research (3)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Blood chemical exposures and B‑cell blood cancer risk

  Researchers will use advanced blood chemical testing and AI to find environmental exposures linked to B‑cell blood cancers like non‑Hodgkin lymphoma and multiple myeloma.

  NIH research Emory University · Atlanta, United States · NIH-11233248

• How opioids affect cancer treatment in blood cancers

  This study looks at how pain medications called opioids might affect the success of chemotherapy for people with blood cancers like acute lymphoblastic leukemia and chronic myeloid leukemia, helping to find better ways to manage pain while treating cancer.

  NIH research University of Utah · Salt Lake City, United States · NIH-10895587

• Understanding environmental risks for blood cancers

  This study is looking at how things in our environment might increase the risk of developing certain blood cancers, like non-Hodgkin lymphoma and multiple myeloma, by analyzing blood samples from patients to find clues that could help us understand this connection better.

  NIH research Emory University · Atlanta, United States · NIH-10810720

Related topics

Quick answers

How many Blood Cancer clinical trials are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (11 trials), Spain (1 trial), United Kingdom (1 trial), Australia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →